Internal Medicine, Hematology & Oncology · Weston, FL
NPI
1821058116
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2950 Cleveland Clinic Blvd
Weston, FL, 33331
Phone (954) 659-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
1,012 services
Medicare patients, 2024
250
Average age 76
Drug cost, 2024
$9.0M
1,100 prescriptions
Company payments, 2025
$1,183
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chieh-Lin Fu was code 99214 (office e&m - established), 349 times for 174 patients. In total Chieh-Lin Fu billed 1,012 services in 18 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 349 | 174 | $72.20 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 264 | 150 | $13.40 | $3,537 |
| 99215 Office E&M - Established | Facility | 215 | 82 | $118.36 | $25K |
| 99233 Hospital E&M - Subsequent | Facility | 56 | 21 | $97.78 | $5,475 |
| 99214 Office E&M - Established | Office | 37 | 29 | $73.22 | $2,709 |
| 99205 Office E&M - New | Facility | 24 | 24 | $138.37 | $3,321 |
By year: 2022 $3.3M for 159,967 services; 2023 $1.4M for 63,003 services; 2024 $72K for 1,012 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chieh-Lin Fu prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 152 prescriptions and refills. In total Chieh-Lin Fu wrote 1,100 Medicare prescriptions that cost $9.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 152 | 152 | 16 | $2.6M |
| Acyclovir Generic | 102 | 170 | 31 | $1,204 |
| Brukinsa Zanubrutinib | 87 | 87 | 11 | $1.1M |
| Hydroxyurea Generic | 76 | 151 | 20 | $1,297 |
| Revlimid Lenalidomide | 54 | 54 | Under 11 | $1.0M |
| Pomalyst Pomalidomide | 46 | 46 | Under 11 | $983K |
| Imbruvica Ibrutinib | 38 | 40 | Under 11 | $676K |
| Allopurinol Generic | 37 | 77 | 20 | $370 |
| Pegasys Peginterferon Alfa-2a | 36 | 36 | Under 11 | $110K |
| Ninlaro Ixazomib Citrate | 35 | 35 | Under 11 | $452K |
| Eliquis Apixaban | 32 | 40 | Under 11 | $24K |
| Imatinib Mesylate Generic | 27 | 27 | Under 11 | $4,817 |
| Calquence Acalabrutinib Maleate | 25 | 25 | Under 11 | $377K |
| Iclusig Ponatinib Hcl | 23 | 23 | Under 11 | $491K |
| Dexamethasone Generic | 20 | 28 | Under 11 | $206 |
Brand drugs: 612 claims; generic drugs: - claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chieh-Lin Fu $1,183 ($1,183 in general payments such as food, travel and fees) from 14 companies. The largest payer was Janssen Biotech, Inc. with $313.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 9 | $313 |
| GlaxoSmithKline, LLC. GSK | 10 | $256 |
| Celgene Corporation BMY | 6 | $117 |
| Pfizer Inc. PFE | 5 | $102 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $76.25 |
| Taiho Oncology, Inc. 4578.T | 3 | $74.8 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $52.31 |
| Merck Sharp & Dohme LLC MRK | 3 | $52.11 |
| Sobi, Inc SOBI.ST | 2 | $37.81 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $33.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.